Skip to content

Difference in pharmacokinetics of antibiotics during pregnancy in normal, overweight and obese women.

Difference in pharmacokinetics of antibiotics during pregnancy in normal, overweight and obese women. - DinAbO - study

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52470
Enrollment
80
Registered
2020-07-02
Start date
2020-08-22
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BMI-related Postsurgical prophylaxis after caesarean section

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1) Older than 18 years of age 2) Admitted at the Department of Obstetrics at Erasmus MC - Sophia for caesarean section. 3) Understanding of Dutch in speaking and reading. 4) Written informed consent.

Exclusion criteria

Exclusion criteria: 1) Women unable or unwilling to agree with the procedures. 2) Women unable or unwilling to give written informed consent. 3) Women with acute obstetric complications requiring immediate delivery at time of admission. 4) Women with interacting drugs, this can influence PK.

Design outcomes

Primary

MeasureTime frame
To examine the maternal pharmacokinetics of standard antibiotic regimen admitted at the Department of Obstetrics at the Erasmus MC - Sophia for antibiotic treatment for postsurgical prophylaxis after caesarean section. Farmacokinetic parameters, which will be determined are: distribution (VD), clearance (Cl), elimination-rate constant (kel), steady-state concentration (Css), half-life (t1/2), bioavailability (F).

Secondary

MeasureTime frame
1. To examine the relation between the weight category (1. BMI 40) before conception and the pharmacokinetics of the antibiotic regimen (primary objective). 2. To examine the relation between the gestational age (weeks) and the pharmacokinetics of the antibiotic regimen (primary objective). 3. To examine the relation between maternal age (years) and the pharmacokinetics of the antibiotic regimen (primary objective). 4. To examine the relation between fetal sex and the pharmacokinetics of the antibiotic regimen (primary objective). 5. To examine the relation between maternal SNPs in cytochrome P450 isoenzyme genes and the pharmacokinetics of the antibiotic regimen (primary objective).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)